10 biotech executives

Beyond their current top jobs, these biotech executives have held senior posts at GSK, Roche, Genentech, Bayer, Shire or Amgen, university posts, roles at venture firms such as Atlas Venture, PureTech Health and Lux Capital, and chief business officer seats. Nine are CEOs and one is President and Chief Operating Officer of Twist Bioscience. Founders taking a lead program from research into the clinic can compare those views.

10 professionals10 companiesData retrieved September 29, 2026

Professionals to explore

  1. Akhila Kosaraju, M.D.

    LinkedIn

    Experience: CEO and President · Phare Bio

    Akhila Kosaraju, M.D., co-founded Phare Bio and has been its CEO and President since 2021; it is a social venture using AI to develop novel antibiotics with the Collins Lab at MIT. Co-Founder and CEO of Variant Bio (2018-2020), EIR at Lux Capital (2020-2021) and Lecturer Senior Advisor at Stanford University (since 2017) round out a record suited to social venture and AI-driven antibiotic discovery models.

    Is this you? Claim your profile and get paid for calls.

  2. Bernat Olle

    LinkedIn

    Experience: Chief Executive Officer, founder, Board of Directors · Vedanta Biosciences, Inc.

    Bernat Olle founded Vedanta Biosciences, Inc. in 2012 and has been Chief Executive Officer, founder, Board of Directors there since 2015. Concurrent roles as Venture Partner at PureTech Health (2007-2016) and Co-Founder of Follica, Inc. (2007-2015) make Bernat Olle a fit for questions on founding a company while also holding a venture partner role.

    Is this you? Claim your profile and get paid for calls.

  3. Blaine McKee

    LinkedIn

    Experience: President and Chief Executive Officer · Walden Biosciences

    Blaine McKee has been President and Chief Executive Officer of Walden Biosciences since 2020. Previous roles were Executive Vice President and Chief Business Officer at ImmunoGen, Inc. (2018-2019), Senior Vice President, Head of Corporate Development (2016-2018) and Senior Vice President, Head of Transactions (2014-2016) at Shire, and EVP and Chief Business Officer at 480 BIOMEDICAL (2011-2014), a fit for corporate development and deal questions.

    Is this you? Claim your profile and get paid for calls.

  4. Carl Hansen

    LinkedIn

    Experience: Chief Executive Officer · AbCellera

    Carl Hansen has been Chief Executive Officer of AbCellera since 2012 and was a Professor at The University of British Columbia (2005-2019), where the title has been Adjunct Professor since 2019. Co-founder & Director (2011-2015) and Scientific Advisor (2015-2021) roles at Precision NanoSystems, Inc. round out a record suited to questions on combining a university professorship with running a company.

    Is this you? Claim your profile and get paid for calls.

  5. Di Hong

    LinkedIn

    Experience: Chief Executive Officer · Nona Biosciences

    Chief Executive Officer of Nona Biosciences since 2025, a company built on fully human heavy chain only antibodies (HCAb/VHH) and its Harbour Mice platform. Di Hong was CEO of Gaoyue Life Science Group (Hillhouse Rava) (2022-2025), Vice President, Corporate Operation & Strategic Alliance at Hua Medicine (2021-2022) and Head of Operations at BioDuro (2019-2021) and Amgen (2014-2019).

    Is this you? Claim your profile and get paid for calls.

  6. Dr. Judy Chou

    LinkedIn

    Experience: President, Chief Executive Officer, and Board Member · AltruBio Inc.

    As President, Chief Executive Officer, and Board Member of AltruBio Inc. since 2020, Dr. Judy Chou leads a biotech after serving as Global Head of Biotech & Senior Vice President, and Bayer Berkeley Site Head at Bayer (2017-2020). Earlier work includes a VP role at Pfizer and research faculty at Harvard, and board seats at Akero Therapeutics and the California Institute for Regenerative Medicine (CIRM).

    Is this you? Claim your profile and get paid for calls.

  7. Hal Barron

    LinkedIn

    Experience: CEO and Founder Board Co-Chair · Altos Labs

    CEO and Founder Board Co-Chair of Altos Labs since 2022, a company focused on restoring cell health and resilience through cell rejuvenation. Hal Barron was Chief Scientific Officer and President, Research & Development at GSK (2018-2022), President, Research & Development at Calico Life Sciences (2014-2017), EVP, Head of Global Product Development & Chief Medical Officer at Roche (2009-2014) and SVP of Development, Chief Medical Officer at Genentech (2003-2009).

    Is this you? Claim your profile and get paid for calls.

  8. Michael Curtis

    LinkedIn

    Experience: President and CEO · eGenesis

    President and CEO of eGenesis since 2022 and President of R&D there (2020-2022). At Cadent Therapeutics, Michael Curtis was President and CEO (2014-2019), President and Head of R&D (2019-2020) and Senior Advisor (2020), so moving between the R&D lead and CEO roles at two companies is the natural topic for a call.

    Is this you? Claim your profile and get paid for calls.

  9. Patrick Finn

    LinkedIn

    Experience: President and Chief Operating Officer · Twist Bioscience

    Patrick Finn has been President and Chief Operating Officer of Twist Bioscience, a synthetic biology company focused on gene synthesis and oligo pools, since 2022. Earlier Twist titles were Chief Commercial Officer (2019-2022) and SVP Commercial Operations (2015-2019), and board seats include ONI (since 2021) and Revelar Biotherapuetics (2021-2022), which suits questions on scaling commercial and operations functions in a synthetic biology company.

    Is this you? Claim your profile and get paid for calls.

  10. Vishal Patel

    LinkedIn

    Experience: Chief Executive Officer · Triveni Bio

    Vishal Patel is CEO of Triveni Bio (since 2022), a privately held, clinical-stage company developing antibody therapeutics for immunological and inflammatory disorders, and an Entrepreneur In Residence at Atlas Venture. Venture roles at Atlas Venture and Flagship Pioneering are described, along with a board seat at Leonardo and reserve roles with the Defense Innovation Unit and the US Navy.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For clinical development strategy, Hal Barron and Michael Curtis have held several R&D leadership titles between them. Founder-CEO questions fit Bernat Olle or Akhila Kosaraju, Carl Hansen fits combining a professorship with a CEO role, and Vishal Patel fits combining a CEO role with venture work; partnering and deal questions fit Blaine McKee; and Patrick Finn, Di Hong and Judy Chou cover commercial operations, operations and running a site inside Bayer.

Questions to take into the conversation

  1. 01What evidence should a biotech have in hand before it commits its lead program to a first-in-human study?
  2. 02How should a biotech CEO sequence financing, hiring and manufacturing work in the year before entering the clinic?
  3. 03When is a partnership with a large pharma company worth taking for a lead program, and what terms should a biotech refuse?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Biotechnology